AGP Executive Report
Last update: 5 hours agoLEAP Africa Leadership: A fifth cohort of the LEAP Africa Leadership Accelerator Programme for young women has brought together 4,500 participants from 48 African countries and 12 non-African countries, with 1,500 completing the online phase and 31 selected for a physical boot camp in Nairobi—highlighting leadership plus health and wellbeing as part of the mission. New Brain Drug Buzz: Researchers are hailing “overporexton” as an “Ozempic for the brain” concept, built around orexin biology to help keep people awake and potentially support up to 15 brain conditions, after approval for narcolepsy. Imported Chikungunya Risk: Hungary has confirmed an imported chikungunya case in a woman who returned from Mauritius during the virus incubation period, underlining how travel can seed mosquito-borne outbreaks. Malaria Progress: WHO-backed RTS,S malaria vaccine rollout continues to prevent millions of cases and deaths across Africa, with new progress also noted for treatments designed for newborns and young infants. Mauritius-Linked Health & Care Business: Redcliffe Labs appoints Ramesh Krishnan as an independent director as it expands from pathology into integrated diagnostics with radiology and preventive healthcare. Health Sector Capacity Building: India’s MoHFW launched a two-day National Mission Karmayogi conference for health sector development officers to strengthen competency-based capacity building. Energy Security (Health Indirect): India signed a long-term supply arrangement with Mauritius for petrol, diesel and aviation fuel, supporting continuity of services during regional disruptions.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.